VEGF-C Shown to Have Major Role in AMD
Kameran Lashkari, MD, of The Schepens Eye Research
Institute at Harvard Medical School, presented data at ARVO showing a major link between VEGF-C levels and
AMD. He indicated that the drug candidate, VGX-300
(a soluble form of VEGF receptor-3 that blocks VEGF-C
and VEGF-D, Opthea Pty Ltd) shows potential as a new
ther...